Dynavax Technologies
Get Full AccessDescription
- Dynavax Technologies Corporation is a clinical-stage biopharmaceutical company that develops products to prevent and treat infectious and inflammatory diseases and cancer. Our clinical-stage product candidates include:Phase 3 HEPLISAV-B Adult Hepatitis B VaccinePhase 1/2 Cancer ImmunotherapyPhase 2 Asthma Therapy - Partnered with AstraZenecaIn Europe, Dynavax manufactures Hepatitis B surface antigen for HEPLISAV-B.
-
Headquarters:2100 Powell Street Suite 900, Emeryville, California, United States
More -
Phone Number: +1 510-848-5100
-
Website: https://www.dynavax.com
-
Employees:222
-
Revenue:$250 - 500M
-
Legal Name:Dynavax Technologies
-
Dynavax Technologies's Social Media
- Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding Dynavax Technologies
-
Where are Dynavax Technologies's Headquarters?
Dynavax Technologies's Headquarters are in 2100 Powell Street Suite 900,Emeryville,California,United States
-
What is Dynavax Technologies's phone number?
Dynavax Technologies's phone number is +1 510-848-5100
-
What is Dynavax Technologies's official website?
Dynavax Technologies's official website is https://www.dynavax.com
-
What is Dynavax Technologies's Revenue?
Dynavax Technologies's revenue is $250 - 500M
-
What is Dynavax Technologies's NAICS code?
Dynavax Technologies's NAICS code is 541713
-
How many employees are working in Dynavax Technologies
Dynavax Technologies has 222 employees
-
What is Dynavax Technologies's Industry?
Dynavax Technologies is in the industry of Biotechnology
-
Who is Dynavax Technologies's CEO?
Dynavax Technologies's CEO is Dino Dina